Wells Fargo’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $128M | Sell |
|
|||||
|
2025
Q2 | $105M | Buy |
|
|||||
|
2025
Q1 | $81M | Buy |
|
|||||
|
2024
Q4 | $65.2M | Buy |
|
|||||
|
2024
Q3 | $73.3M | Buy |
|
|||||
|
2024
Q2 | $50.1M | Sell |
|
|||||
|
2024
Q1 | $30.8M | Sell |
|
|||||
|
2023
Q4 | $44M | Sell |
|
|||||
|
2023
Q3 | $47.1M | Buy |
|
|||||
|
2023
Q2 | $49.2M | Buy |
|
|||||
|
2023
Q1 | $49M | Buy |
|
|||||
|
2022
Q4 | $47.4M | Buy |
|
|||||
|
2022
Q3 | $12.8M | Sell |
|
|||||
|
2022
Q2 | $10.6M | Buy |
|
|||||
|
2022
Q1 | $10.5M | Buy |
|
|||||
|
2021
Q4 | $7.66M | Sell |
|
|||||
|
2021
Q3 | $25.7M | Sell |
|
|||||
|
2021
Q2 | $24.9M | Sell |
|
|||||
|
2021
Q1 | $22M | Sell |
|
|||||
|
2020
Q4 | $28.4M | Sell |
|
|||||
|
2020
Q3 | $36.3M | Buy |
|
|||||
|
2020
Q2 | $35.8M | Sell |
|
|||||
|
2020
Q1 | $27.1M | Buy |
|
|||||
|
2019
Q4 | $8.57M | Buy |
|
|||||
|
2019
Q3 | $5.09M | Sell |
|
|||||
|
2019
Q2 | $4.64M | Buy |
|
|||||
|
2019
Q1 | $5.43M | Sell |
|
|||||
|
2018
Q4 | $4.32M | Sell |
|
|||||
|
2018
Q3 | $17.5M | Buy |
|
|||||
|
2018
Q2 | $19.4M | Buy |
|
|||||
|
2018
Q1 | $14.1M | Sell |
|
|||||
|
2017
Q4 | $15.8M | Sell |
|
|||||
|
2017
Q3 | $15.9M | Sell |
|
|||||
|
2017
Q2 | $26.3M | Sell |
|
|||||
|
2017
Q1 | $19.2M | Buy |
|
|||||
|
2016
Q4 | $10.5M | Sell |
|
|||||
|
2016
Q3 | $31.7M | Sell |
|
|||||
|
2016
Q2 | $38.8M | Sell |
|
|||||
|
2016
Q1 | $48.5M | Sell |
|
|||||
|
2015
Q4 | $72.9M | Sell |
|
|||||
|
2015
Q3 | $62.4M | Buy |
|
|||||
|
2015
Q2 | $88.1M | Sell |
|
|||||
|
2015
Q1 | $81.2M | Sell |
|
|||||
|
2014
Q4 | $79.6M | Sell |
|
|||||
|
2014
Q3 | $76.1M | Sell |
|
|||||
|
2014
Q2 | $62.5M | Sell |
|
|||||
|
2014
Q1 | $71.7M | Buy |
|
|||||
|
2013
Q4 | $64.1M | Buy |
|
|||||
|
2013
Q3 | $61.9M | Sell |
|
|||||
|
2013
Q2 | $33.3M | Buy |
|